OTCPK:BSRC

Stock Analysis Report

Executive Summary

BioSolar, Inc. develops technologies and materials for storing electrical energy produced by photovoltaic solar modules.

Snowflake

Fundamentals

Slightly overvalued with questionable track record.

Risks

  • BioSolar has significant price volatility in the past 3 months.
  • BioSolar is not covered by any analysts.

Share Price & News

How has BioSolar's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

23.1%

BSRC

-2.5%

US Semiconductor

-0.6%

US Market


1 Year Return

-52.0%

BSRC

7.5%

US Semiconductor

0.7%

US Market

BSRC underperformed the Semiconductor industry which returned 7.5% over the past year.

BSRC underperformed the Market in United States of America which returned 0.6% over the past year.


Share holder returns

BSRCIndustryMarket
7 Day23.1%-2.5%-0.6%
30 Day-9.6%4.1%2.9%
90 Day28.9%9.9%1.3%
1 Year-52.0%-52.0%9.6%7.5%2.9%0.7%
3 Year-75.0%-75.0%79.9%69.3%44.6%35.2%
5 Year-85.6%-85.6%119.3%97.0%61.9%44.2%

Price Volatility Vs. Market

How volatile is BioSolar's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is BioSolar undervalued based on future cash flows and its price relative to the stock market?

0.071x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for BioSolar to establish if it is available at moderate discount.

Unable to calculate intrinsic value for BioSolar to establish if it is available at substantial discount.


Price Based on Earnings

BioSolar is good value based on earnings compared to the US Semiconductor industry average.

BioSolar is good value based on earnings compared to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for BioSolar, we can't assess if its growth is good value.


Price Based on Value of Assets

BioSolar has negative assets, we can't compare the value of its assets to the US Semiconductor industry average.


Next Steps

Future Growth

How is BioSolar expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

19.0%

Forecasted Semiconductors industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BioSolar has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of BSRC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access BioSolar's filings and announcements here.
  • Explore growth companies in the Semiconductors industry.

Past Performance

How has BioSolar performed over the past 5 years?

1.3%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

BioSolar's year on year earnings growth rate has been positive over the past 5 years.

BioSolar has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.

BioSolar has become profitable in the last year making it difficult to compare the US Semiconductor industry average.


Return on Equity

It is difficult to establish if BioSolar has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

BioSolar used its assets more efficiently than the US Semiconductor industry average last year based on Return on Assets.


Return on Capital Employed

It is difficult to establish if BioSolar improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is BioSolar's financial position?


Financial Position Analysis

BioSolar's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

BioSolar's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

BioSolar has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if BioSolar's debt level has increased considering it has negative shareholder equity.

Operating cash flow is negative therefore debt is not well covered.

Unable to confirm if the interest payments on BioSolar's debt are well covered by earnings due to lack of past financial data.


Balance Sheet

Low level of unsold assets.

BioSolar has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Next Steps

Dividend

What is BioSolar's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate BioSolar's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate BioSolar's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as BioSolar has not reported any payouts.

Unable to verify if BioSolar's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as BioSolar has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of BioSolar's salary, the management and board of directors tenure and is there insider trading?

US$144k

CEO Compensation


CEO

David Lee (60yo)

13.4yrs

Tenure

US$144,000

Compensation

Dr. David D. Lee, Ph.D. has been the Chief Executive Officer and Acting Chief Financial Officer of BioSolar, Inc. since April 24, 2006. Dr. Lee is the Founder of BioSolar Inc. Dr. Lee has over 30 years of ...


CEO Compensation Analysis

David's remuneration is lower than average for companies of similar size in United States of America.

David's compensation has been consistent with company performance over the past year, both up more than 20%.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Stanley Levy (79yo)

    VP & CTO

    • Tenure: 12.1yrs
  • David Lee (60yo)

    Founder

    • Tenure: 13.4yrs
    • Compensation: US$144.00k
  • Charles Carraher

    Scientific Advisor

    • Tenure: 0yrs

Board Members

  • Dennis LePon (72yo)

    Director

    • Tenure: 13.3yrs
  • Steven Bartling (57yo)

    Director

    • Tenure: 13.3yrs
  • David Lee (60yo)

    Founder

    • Tenure: 13.4yrs
    • Compensation: US$144.00k

Company Information

BioSolar, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: BioSolar, Inc.
  • Ticker: BSRC
  • Exchange: OTCPK
  • Founded: 2006
  • Industry: Semiconductor Equipment
  • Sector: Semiconductors
  • Market Cap: US$2.711m
  • Shares outstanding: 110.66m
  • Website: https://www.biosolar.com

Number of Employees


Location

  • BioSolar, Inc.
  • 27936 Lost Canyon Road
  • Suite 202
  • Santa Clarita
  • California
  • 91387
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BSRCOTCPK (Pink Sheets LLC)YesCommon StockUSUSDFeb 2007

Biography

BioSolar, Inc. develops technologies and materials for storing electrical energy produced by photovoltaic solar modules. It offers BioBacksheet, a green back sheet for photovoltaic solar modules. The compa ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/22 00:09
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.